Octreotide and pancreatic perfusion on the outcome of experimental acute pancreatitis

Digestive Surgery

Volumn 13, Issue 6, 1996, Pages 460-464

  Kotzampassi, K ^a   Eleftheriadis, E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Experimental acute; Ischemia; Laser Doppler flowmetry; Octreotide; Pancreatic; Pancreatitis; Taurocholate pancreatitis; Tissue perfusion

Indexed keywords

OCTREOTIDE; TAUROCHOLIC ACID;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROL; CONTROLLED STUDY; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PANCREAS PERFUSION; PROPHYLAXIS; RAT; SPLANCHNIC BLOOD FLOW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029809539     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172489     Document Type: Article

References (39)

1. Kiar E, Mcssmer K, Warshaw AL, et al: Pancreatic ischaemia in experimental acute pancreatitis: Mechanism, significance and therapy, Br J Surg 1990;77:1205-1210.
2. Bassi D, Kollias N, Fcmandcz-del Castillo C, et al: Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis, J Am Coll Surg 1994; 179:257-263.
3. Yotsumoto F, Manabe T, Ohshio G, et al: Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis, J Surg Res 1993:55:531-536.
4. McEntec G, Leahy A, Cottcll D, et al: Three-dimensional morphological study of the pancreatic microvasculaturc in caerulcin-induccd experimental pancreatitis, Br J Surg 1989;76: 853-855.
5. Knoefel WT, Kollias N, Warshaw AL, et al: Altered pancreatic perfusion in pancreatitis of increased severity (abstract), Gastroenterology 1991:100:280.
6. Klar E, Herfarth C, Mcssmer K: Therapeutic effect of isovolemic hemodilulion with dextran 60 on the impairment of pancreatic niicrocir-culation in acute biliary pancreatitis, Ann Surg 1990;211:346-354.
7. Haas GS, Warshaw AL, Daggett WM, et al: Acute pancreatitis after cardiopulmonary bypass, Am J Surg 1985:149:508-515.
8. Warshaw AL, O’Hara PJ: Susceptibility of the pancreatic to ischemic injury in shock, Ann Surg 1978:188:197-201.
9. Choi TK, Mole F, Zhan WH, Fan ST, et al: Somatostatin in the trcamcnt of acute pancreatitis: A prospective randomized controlled trial, Gut 1989;30:223-227.
10. Baxter JN, Ellenbogen S, Roberts N, et al: The effects of a somatostatin analogue SMS 201 -995 on pancreatic secretion in the pig and in man, Surg ResCommun 1988:4:215-228.
11. Naruse S, Suzuki T, Yanaihara N: Effect of subcutaneous injection of somatostatin analogue SMS 201-995 on exocrine pancreatic secreton in dogs (abstract 210), Digestion 1990: 46(suppl 1):76.
12. Baxter JN, Jenkins SA, Day DW, et al: Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat, BrJ Surg 1985;72:382-385.
13. Murayama KM, Joehl RJ: Does somatostatin analogue prevent experimental acute pancreatitis? Arch Surg 1990:125:1570-1572.
14. Niederau C, Schulz HU: Current conservative treatment of acute pancreatitis, Evidence from animal and human studies, Hepatogastrocntcr-ologv 1993:40:538-549.
15. Steinberg WM, Schlessclman SE: Treatment of acute pancreatitis: Comparison of animal and human studies, Gastroenterology 1987:93: 1420-1427.
16. Beechey-Newman N: Controlled trial of high-dose octreotide in treatment of acute pancreatitis, Evidence of improvement in disease severity, DigDisSci 1993:38:633-647.
17. Lamers CBHW: Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract, Acta Endocrinol 1987(suppl 286): 19-25.
18. Masclce AAM, Jansen JBMI, Earners CBHW: Evaluation of somatostatin and somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders, Neth J Med 1991: 39:356-365.
19. Price BA, Jaffc BM, Zinncr MJ: Effect of exogenous Somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog, Gastroenterology 1985:88:80-85.
20. Conway DR, Djuricin G, Prinz A: The ctfcct of somatostatin analogue SMS 201-995 on pancreatic blood flow', Surgery X 988; 104:1024-1030.
21. Toriunti Y, Samuel I, Wilcockson DP, et al: Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis, J Lab Clin Med 1993:122:450-454.
22. Schroder T, Millard RW, Nakajima Y, et al: Microcirculatory effects of somatostatin in acute pancreatitis, Eur Surg Res 1988:20:82-88.
23. Sever M, Korosec L, Ccrar A, et al: A model of experimental acute pancreatitis, Res Surgery 1992:4:42-45.
24. Nilsson GE: Perimed’s LDF flowmeter: in Shepherd AP, Öberg PA (eds): Laser Doppler Flowmctry, Boston, Kluwer Academic, 1990. p 57.
25. Salcrud EG, Öberg PA: Single-fiber laser Doppler flowmetry, A method for deep tissue perfusion measurements, Med Biol Eng Corn-put 1987:25:329-331.
26. Klar E, Mall G, Messmer K, et al: Improvement of impaired pancreatic microcirculation by isovolemic hemodilulion protects pancreatic morphology in acute pancreatitis, Surg Gynecol Obstet 1993:176:144-150.
27. Bockman DE: Microvasculaturc of the pancreas, Int J Pancreatol 1992;12:11-21.
28. Kusterer K, Friedemann A, Poschmann T, et al: Ischemia-reperfusion and leukocyte adherence at acute pancreatitis (abstract 331), 5th World Congr Mierocirculation, Louisville, 1991.
29. Borim AA, Fondacaro PF, Holm C, et al: The effect of Somatostatin analogue on pancreatic capillary blood flow during acute pancreatitis (abstract), Gastroenterology 1990:98:214.
30. Jenkins SA, Ellenbogen S, Kvnaston H, et al: The effects of Sandostatin (SMS) on pancreatic blood flow, structure and function during the development of experimentally induced acute pancreatitis (abstract P097), HPB Surg 1992: 5(suppl):64.
31. Jenkins SA, Kynaston H, Davis N, el al: San-dostalin (SMS) ameliorates the deleterious effects of endotoxin on pancreatic structure, function and blood flow in rats (abstract P098), HPB Surg 1992;5(suppl):64.
32. Kelly DM, McEntee GP, McGceney KF, et al: Microvasculaturc of the pancreas, liver and kidney and cerulein-induced pancreatitis, Arch Surg 1993:128:293-295.
33. Kelly DM, McEntee GP, Delaney C, et al: Temporal relationship of acinar and microvas-cular changes in cerulein-induced pancreatitis, BrJ Surg 1993; 180:1174-1176.
34. Sysed AS: Angioarchitecturc of the pancreas in the cat, Cell Tissue Res 1984:235:681-682.
35. Schiller WR, Anderson MC: Mierocirculation of the normal and inflamed canine pancreas, Ann Surg 1975;181:466-470.
36. Nuutmen P, Kivisaari L, Standcrtskjold-Nor-Denstram CG, et al: Microangiography of the pancreas in experimental oedcmic and haern-orrhagic pancreatitis, Scand J Gastroenterol 1986;21:12-17.
37. Bilchik AJ, Leach SD, Zucker KA, et al: Experimental models of acute pancreatitis, J Surg Res 1990:48:639-647.
38. van Ooijen B, Tinga CJ, Kort WJ, et al: Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis, Dig DisSei 1992:37:1434-1440.
39. Toledano AE, Reis ED, Ribciro MLB, et al: The effect of secretin and somatostatin analogue (SMS 201-995) on survival in taurocho-lale-induccd acute pancreatitis, Pancreas 1988: 3:620.